Luisa Torres, PhD
Luisa is an assistant science editor at Drug Discovery News. She has a PhD in Molecular and Cellular Pharmacology from Stony Brook University where she researched anti-inflammatory treatments for spinal cord injury. Later, as a postdoctoral fellow, she studied how parasitic infections may lead to signs of Alzheimer’s disease. She has written for NPR’s blogs ‘Shots’, ‘The Salt ‘and ‘Goats and Soda’. Her interests include metabolism, aging and drug discovery.
Articles by Luisa Torres, PhD
| 2 min read
Dopamine stimulators may lessen the systemic side effects — often weight gain and diabetes — of dopamine-blocking antipsychotics.
| 3 min read
An inhibitory receptor binds a checkpoint protein to thwart T cell proliferation and function.
| 3 min read
Plectasin forms dense structures on bacterial membranes by binding to unique lipids in bacterial cell walls.
| 5 min read
Clinical trial insights refine early-stage toxicology evaluations, yielding safer medicines.
| 2 min read
Cancer cells with mutated p53 undergo apoptosis by stalling ribosomes at rare leucine codons, inhibiting protein translation.
| 5 min read
The durability and capacity to boost protein expression of circular RNA makes it a promising candidate for next-generation vaccines and gene therapies.
| 9 min read
Lifestyle and genetics intertwine to shape individual risk and the pathway to prediabetes reversal.
| 5 min read
Inspired by nature, Peel Therapeutics scientists look to evolution to find the next life changing drug.
| 3 min read
Antibodies that are a fraction of the size of a regular antibody protect against key toxins in snake venom and could potentially replace 130-year-old treatments.
| 3 min read
In rheumatoid arthritis, damaged joints contain fibroblasts that prompt nerve cell growth, potentially causing pain even in the absence of inflammation.
| 3 min read
An experimental drug significantly reduced tumor burden and extended survival in mice with pancreatic cancer.
| 3 min read
Targeting α-synuclein mRNA before it had a chance to aggregate reduced its protein levels in cultured dopaminergic neurons and may protect neurons.
